tert-butyl 4-(3-(methoxycarbonyl)benzyl)piperazine-1-carboxylate

Catalog No. :
ACVTUZ882
CAS No. :
203047-36-3
Molecular Formula :
C18H26N2O4
Molecular Weight :
334.42

IUPAC Name:tert-butyl 4-(3-(methoxycarbonyl)benzyl)piperazine-1-carboxylate

tert-butyl 4-(3-(methoxycarbonyl)benzyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 4-(3-(methoxycarbonyl)benzyl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(3-(methoxycarbonyl)benzyl)piperazine-1-carboxylate
Molecular FormulaC18H26N2O4
Molecular Weight334.42
SMILESCOC(=O)C1=CC=CC(CN2CCN(C(=O)OC(C)(C)C)CC2)=C1
InChI KeyKQKSAJRTFZKQCO-UHFFFAOYSA-N
SynonymTERT-BUTYL 4-[3-(METHOXYCARBONYL)BENZYL!PIPERAZINE-1-CARBOXYLATE, 97+%;tert-Butyl 4-[3-(methoxycarbonyl)-benzyl]piperazine-1-carboxylate;tert-Butyl 4-[2-(methoxycarbonyl)-benzyl]piperazine-1-carboxylate;2-Methyl-2-propanyl 4-[3-(methoxycarbonyl)benzyl]-1-piperazinecarboxylate;t-butyl-4-[3-1-(methoxycarbonyl)benzyl]piperazine-1-carbxyla;1-Piperazinecarboxylic acid, 4-[[3-(methoxycarbonyl)phenyl]methyl]-, 1,1-dimethylethyl ester
CAS No.203047-36-3

Synthetic Route by SureRoute

1. ACVTUZ882 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVTUZ882 route product structure diagram
    ACVTUZ882203047-36-3
Inquiry

2. ACVTUZ882 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACVTUN083 route compound structure diagram
    ACVTUN08352178-50-4 In Stock
  4. Then
  5. ACVTUZ882 route product structure diagram
    ACVTUZ882203047-36-3
Inquiry

Comments (0)